Suresh Mallikaarjun

Suresh Mallikaarjun

Otsuka Pharmaceutical Co. Ltd. - Tokyo / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4971065
大塚製薬株式会社 大塚製薬株式会社
person_outline Suresh Mallikaarjun's MOST POPULAR ARTICLES
1-) Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers S Mallikaarjun, DE Salazar, SL Bramer The Journal of Clinical Pharmacology 44 (2), 179-187, 2004 2212004
2-) Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator R Kubota, NL Boman, R David, S Mallikaarjun, S Patil, D Birch Retina 32 (1), 183-188, 2012 1072012
3-) Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose studyS Mallikaarjun, JM Kane, P Bricmont, R McQuade, W Carson, R Sanchez, ...Schizophrenia research 150 (1), 281-288, 20131112013
4-) Pharmacokinetics, pharmacodynamics, and safety of tolvaptan, a nonpeptide AVP antagonist, during ascending single‐dose studies in healthy subjectsSE Shoaf, Z Wang, P Bricmont, S MallikaarjunThe Journal of Clinical Pharmacology 47 (12), 1498-1507, 20071112007
5-) Pharmacokinetics of aripiprazole and concomitant lithium and valproateL Citrome, R Josiassen, N Bark, DE Salazar, S MallikaarjunThe Journal of Clinical Pharmacology 45 (1), 89-93, 20051052005